Feb 13, 2021
You may already know this but several meta-analyses have found that COPD prevalence is low among COVID-19 patients compared to other medical comorbidities (e.g., hypertension, diabetes) by a wide margin. However, COPD patients do indeed face an increased risk of more severe COVID-19.
If COPD is ''a disease of white men'', that may explain the lower prevalence of COPD among COVID-19 patients since people of color are more likely to get hospitalized. And that may also mean COPD prevalence among COVID-19 patients are not relatively low, after all, given that COPD is underdiagnosed in certain populations.
Examples of meta-analysis:
